Trial Profile
Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Mar 2019
Price :
$35
*
At a glance
- Drugs Ubidecarenone (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- 17 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Feb 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 22 May 2009 Location (USA) identified as reported by ClinicalTrials.gov.